SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-010201
Filing Date
2021-01-15
Accepted
2021-01-15 17:01:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d226607ds3.htm S-3 302832
2 EX-4.9 d226607dex49.htm EX-4.9 283532
3 EX-5.1 d226607dex51.htm EX-5.1 20281
4 EX-23.1 d226607dex231.htm EX-23.1 1679
5 GRAPHIC g226607g10i78.jpg GRAPHIC 49268
6 GRAPHIC g226607snap0001.jpg GRAPHIC 5231
  Complete submission text file 0001193125-21-010201.txt   678585
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252170 | Film No.: 21532833
SIC: 3826 Laboratory Analytical Instruments